aluates Reports

$ 0.0

Automative

Global AI Pharma Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-7D11664

Global AI Pharma Market Research Report 2022

BUY CHAPTERS

Global AI Pharma Market Research Report 2025

Code: QYRE-Auto-7D11664

Report

March 2025

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

InSilico Medicine

Exscientia Ltd

BenevolentAI

Atomwise

Roivant Sciences

Schrödinger

XtalPi

Landos Biopharma

Deep Genomics

Recursion

Lantern Pharma

Relay Therapeutics

Accutar Biotech

Oncocross

AI Therapeutics

BioMap

METiS Pharmaceuticals

NeoX Biotech

StoneWise

Deep Intelligent Pharma

Gigaceuticals

Chemical.AI

Artivila

Galixir

Xbiome

AI Pharma Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

AI Pharma Market

The global market for AI Pharma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for AI Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Pharma.

The AI Pharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Pharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI Pharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of AI Pharma Market Report

Report Metric	Details
Report Name	AI Pharma Market
CAGR	5%
Segment by Type	Self-developed Oipeline Contract Research Organization (CRO) Other
Segment by Application	Preclinical Stage (Optimization of Lead Compounds, etc.) Clinical Trial Phase (Predicting Treatment Outcome, etc.)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schrödinger, Lantern Pharma, XtalPi, Landos Biopharma, Relay Therapeutics, Accutar Biotech, Deep Genomics, Oncocross, AI Therapeutics, BioMap, METiS Pharmaceuticals, NeoX Biotech, StoneWise, Deep Intelligent Pharma, Gigaceuticals, Chemical.AI, Artivila, Galixir, Xbiome
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Pharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI Pharma Market report?

Ans: The main players in the AI Pharma Market are Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schrödinger, Lantern Pharma, XtalPi, Landos Biopharma, Relay Therapeutics, Accutar Biotech, Deep Genomics, Oncocross, AI Therapeutics, BioMap, METiS Pharmaceuticals, NeoX Biotech, StoneWise, Deep Intelligent Pharma, Gigaceuticals, Chemical.AI, Artivila, Galixir, Xbiome

What are the Application segmentation covered in the AI Pharma Market report?

Ans: The Applications covered in the AI Pharma Market report are Preclinical Stage (Optimization of Lead Compounds, etc.), Clinical Trial Phase (Predicting Treatment Outcome, etc.)

What are the Type segmentation covered in the AI Pharma Market report?

Ans: The Types covered in the AI Pharma Market report are Self-developed Oipeline, Contract Research Organization (CRO), Other

Recommended Reports

Pharma Automation

Pharma Services

Pharma Drugs Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Pharma Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Self-developed Oipeline

1.2.3 Contract Research Organization (CRO)

1.2.4 Other

1.3 Market by Application

1.3.1 Global AI Pharma Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Preclinical Stage (Optimization of Lead Compounds, etc.)

1.3.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI Pharma Market Perspective (2020-2031)

2.2 Global AI Pharma Growth Trends by Region

2.2.1 Global AI Pharma Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 AI Pharma Historic Market Size by Region (2020-2025)

2.2.3 AI Pharma Forecasted Market Size by Region (2026-2031)

2.3 AI Pharma Market Dynamics

2.3.1 AI Pharma Industry Trends

2.3.2 AI Pharma Market Drivers

2.3.3 AI Pharma Market Challenges

2.3.4 AI Pharma Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Pharma Players by Revenue

3.1.1 Global Top AI Pharma Players by Revenue (2020-2025)

3.1.2 Global AI Pharma Revenue Market Share by Players (2020-2025)

3.2 Global AI Pharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by AI Pharma Revenue

3.4 Global AI Pharma Market Concentration Ratio

3.4.1 Global AI Pharma Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Pharma Revenue in 2024

3.5 Global Key Players of AI Pharma Head office and Area Served

3.6 Global Key Players of AI Pharma, Product and Application

3.7 Global Key Players of AI Pharma, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 AI Pharma Breakdown Data by Type

4.1 Global AI Pharma Historic Market Size by Type (2020-2025)

4.2 Global AI Pharma Forecasted Market Size by Type (2026-2031)

5 AI Pharma Breakdown Data by Application

5.1 Global AI Pharma Historic Market Size by Application (2020-2025)

5.2 Global AI Pharma Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America AI Pharma Market Size (2020-2031)

6.2 North America AI Pharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America AI Pharma Market Size by Country (2020-2025)

6.4 North America AI Pharma Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Pharma Market Size (2020-2031)

7.2 Europe AI Pharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe AI Pharma Market Size by Country (2020-2025)

7.4 Europe AI Pharma Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI Pharma Market Size (2020-2031)

8.2 Asia-Pacific AI Pharma Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific AI Pharma Market Size by Region (2020-2025)

8.4 Asia-Pacific AI Pharma Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI Pharma Market Size (2020-2031)

9.2 Latin America AI Pharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America AI Pharma Market Size by Country (2020-2025)

9.4 Latin America AI Pharma Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Pharma Market Size (2020-2031)

10.2 Middle East & Africa AI Pharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa AI Pharma Market Size by Country (2020-2025)

10.4 Middle East & Africa AI Pharma Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Recursion

11.1.1 Recursion Company Details

11.1.2 Recursion Business Overview

11.1.3 Recursion AI Pharma Introduction

11.1.4 Recursion Revenue in AI Pharma Business (2020-2025)

11.1.5 Recursion Recent Development

11.2 Insilico Medicine

11.2.1 Insilico Medicine Company Details

11.2.2 Insilico Medicine Business Overview

11.2.3 Insilico Medicine AI Pharma Introduction

11.2.4 Insilico Medicine Revenue in AI Pharma Business (2020-2025)

11.2.5 Insilico Medicine Recent Development

11.3 Exscientia

11.3.1 Exscientia Company Details

11.3.2 Exscientia Business Overview

11.3.3 Exscientia AI Pharma Introduction

11.3.4 Exscientia Revenue in AI Pharma Business (2020-2025)

11.3.5 Exscientia Recent Development

11.4 BenevolentAI

11.4.1 BenevolentAI Company Details

11.4.2 BenevolentAI Business Overview

11.4.3 BenevolentAI AI Pharma Introduction

11.4.4 BenevolentAI Revenue in AI Pharma Business (2020-2025)

11.4.5 BenevolentAI Recent Development

11.5 Atomwise

11.5.1 Atomwise Company Details

11.5.2 Atomwise Business Overview

11.5.3 Atomwise AI Pharma Introduction

11.5.4 Atomwise Revenue in AI Pharma Business (2020-2025)

11.5.5 Atomwise Recent Development

11.6 Roivant Sciences

11.6.1 Roivant Sciences Company Details

11.6.2 Roivant Sciences Business Overview

11.6.3 Roivant Sciences AI Pharma Introduction

11.6.4 Roivant Sciences Revenue in AI Pharma Business (2020-2025)

11.6.5 Roivant Sciences Recent Development

11.7 Schrödinger

11.7.1 Schrödinger Company Details

11.7.2 Schrödinger Business Overview

11.7.3 Schrödinger AI Pharma Introduction

11.7.4 Schrödinger Revenue in AI Pharma Business (2020-2025)

11.7.5 Schrödinger Recent Development

11.8 Lantern Pharma

11.8.1 Lantern Pharma Company Details

11.8.2 Lantern Pharma Business Overview

11.8.3 Lantern Pharma AI Pharma Introduction

11.8.4 Lantern Pharma Revenue in AI Pharma Business (2020-2025)

11.8.5 Lantern Pharma Recent Development

11.9 XtalPi

11.9.1 XtalPi Company Details

11.9.2 XtalPi Business Overview

11.9.3 XtalPi AI Pharma Introduction

11.9.4 XtalPi Revenue in AI Pharma Business (2020-2025)

11.9.5 XtalPi Recent Development

11.10 Landos Biopharma

11.10.1 Landos Biopharma Company Details

11.10.2 Landos Biopharma Business Overview

11.10.3 Landos Biopharma AI Pharma Introduction

11.10.4 Landos Biopharma Revenue in AI Pharma Business (2020-2025)

11.10.5 Landos Biopharma Recent Development

11.11 Relay Therapeutics

11.11.1 Relay Therapeutics Company Details

11.11.2 Relay Therapeutics Business Overview

11.11.3 Relay Therapeutics AI Pharma Introduction

11.11.4 Relay Therapeutics Revenue in AI Pharma Business (2020-2025)

11.11.5 Relay Therapeutics Recent Development

11.12 Accutar Biotech

11.12.1 Accutar Biotech Company Details

11.12.2 Accutar Biotech Business Overview

11.12.3 Accutar Biotech AI Pharma Introduction

11.12.4 Accutar Biotech Revenue in AI Pharma Business (2020-2025)

11.12.5 Accutar Biotech Recent Development

11.13 Deep Genomics

11.13.1 Deep Genomics Company Details

11.13.2 Deep Genomics Business Overview

11.13.3 Deep Genomics AI Pharma Introduction

11.13.4 Deep Genomics Revenue in AI Pharma Business (2020-2025)

11.13.5 Deep Genomics Recent Development

11.14 Oncocross

11.14.1 Oncocross Company Details

11.14.2 Oncocross Business Overview

11.14.3 Oncocross AI Pharma Introduction

11.14.4 Oncocross Revenue in AI Pharma Business (2020-2025)

11.14.5 Oncocross Recent Development

11.15 AI Therapeutics

11.15.1 AI Therapeutics Company Details

11.15.2 AI Therapeutics Business Overview

11.15.3 AI Therapeutics AI Pharma Introduction

11.15.4 AI Therapeutics Revenue in AI Pharma Business (2020-2025)

11.15.5 AI Therapeutics Recent Development

11.16 BioMap

11.16.1 BioMap Company Details

11.16.2 BioMap Business Overview

11.16.3 BioMap AI Pharma Introduction

11.16.4 BioMap Revenue in AI Pharma Business (2020-2025)

11.16.5 BioMap Recent Development

11.17 METiS Pharmaceuticals

11.17.1 METiS Pharmaceuticals Company Details

11.17.2 METiS Pharmaceuticals Business Overview

11.17.3 METiS Pharmaceuticals AI Pharma Introduction

11.17.4 METiS Pharmaceuticals Revenue in AI Pharma Business (2020-2025)

11.17.5 METiS Pharmaceuticals Recent Development

11.18 NeoX Biotech

11.18.1 NeoX Biotech Company Details

11.18.2 NeoX Biotech Business Overview

11.18.3 NeoX Biotech AI Pharma Introduction

11.18.4 NeoX Biotech Revenue in AI Pharma Business (2020-2025)

11.18.5 NeoX Biotech Recent Development

11.19 StoneWise

11.19.1 StoneWise Company Details

11.19.2 StoneWise Business Overview

11.19.3 StoneWise AI Pharma Introduction

11.19.4 StoneWise Revenue in AI Pharma Business (2020-2025)

11.19.5 StoneWise Recent Development

11.20 Deep Intelligent Pharma

11.20.1 Deep Intelligent Pharma Company Details

11.20.2 Deep Intelligent Pharma Business Overview

11.20.3 Deep Intelligent Pharma AI Pharma Introduction

11.20.4 Deep Intelligent Pharma Revenue in AI Pharma Business (2020-2025)

11.20.5 Deep Intelligent Pharma Recent Development

11.21 Gigaceuticals

11.21.1 Gigaceuticals Company Details

11.21.2 Gigaceuticals Business Overview

11.21.3 Gigaceuticals AI Pharma Introduction

11.21.4 Gigaceuticals Revenue in AI Pharma Business (2020-2025)

11.21.5 Gigaceuticals Recent Development

11.22 Chemical.AI

11.22.1 Chemical.AI Company Details

11.22.2 Chemical.AI Business Overview

11.22.3 Chemical.AI AI Pharma Introduction

11.22.4 Chemical.AI Revenue in AI Pharma Business (2020-2025)

11.22.5 Chemical.AI Recent Development

11.23 Artivila

11.23.1 Artivila Company Details

11.23.2 Artivila Business Overview

11.23.3 Artivila AI Pharma Introduction

11.23.4 Artivila Revenue in AI Pharma Business (2020-2025)

11.23.5 Artivila Recent Development

11.24 Galixir

11.24.1 Galixir Company Details

11.24.2 Galixir Business Overview

11.24.3 Galixir AI Pharma Introduction

11.24.4 Galixir Revenue in AI Pharma Business (2020-2025)

11.24.5 Galixir Recent Development

11.25 Xbiome

11.25.1 Xbiome Company Details

11.25.2 Xbiome Business Overview

11.25.3 Xbiome AI Pharma Introduction

11.25.4 Xbiome Revenue in AI Pharma Business (2020-2025)

11.25.5 Xbiome Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

InSilico Medicine

Exscientia Ltd

BenevolentAI

Atomwise

Roivant Sciences

Schrödinger

XtalPi

Landos Biopharma

Deep Genomics

Recursion

Lantern Pharma

Relay Therapeutics

Accutar Biotech

Oncocross

AI Therapeutics

BioMap

METiS Pharmaceuticals

NeoX Biotech

StoneWise

Deep Intelligent Pharma

Gigaceuticals

Chemical.AI

Artivila

Galixir

Xbiome

List of Tables

Table 1. Global AI Pharma Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Self-developed Oipeline

Table 3. Key Players of Contract Research Organization (CRO)

Table 4. Key Players of Other

Table 5. Global AI Pharma Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global AI Pharma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global AI Pharma Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global AI Pharma Market Share by Region (2020-2025)

Table 9. Global AI Pharma Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global AI Pharma Market Share by Region (2026-2031)

Table 11. AI Pharma Market Trends

Table 12. AI Pharma Market Drivers

Table 13. AI Pharma Market Challenges

Table 14. AI Pharma Market Restraints

Table 15. Global AI Pharma Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global AI Pharma Market Share by Players (2020-2025)

Table 17. Global Top AI Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pharma as of 2024)

Table 18. Ranking of Global Top AI Pharma Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by AI Pharma Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of AI Pharma, Headquarters and Area Served

Table 21. Global Key Players of AI Pharma, Product and Application

Table 22. Global Key Players of AI Pharma, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global AI Pharma Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global AI Pharma Revenue Market Share by Type (2020-2025)

Table 26. Global AI Pharma Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global AI Pharma Revenue Market Share by Type (2026-2031)

Table 28. Global AI Pharma Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global AI Pharma Revenue Market Share by Application (2020-2025)

Table 30. Global AI Pharma Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global AI Pharma Revenue Market Share by Application (2026-2031)

Table 32. North America AI Pharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America AI Pharma Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America AI Pharma Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe AI Pharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe AI Pharma Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe AI Pharma Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific AI Pharma Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific AI Pharma Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific AI Pharma Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America AI Pharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America AI Pharma Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America AI Pharma Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa AI Pharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa AI Pharma Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa AI Pharma Market Size by Country (2026-2031) & (US$ Million)

Table 47. Recursion Company Details

Table 48. Recursion Business Overview

Table 49. Recursion AI Pharma Product

Table 50. Recursion Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 51. Recursion Recent Development

Table 52. Insilico Medicine Company Details

Table 53. Insilico Medicine Business Overview

Table 54. Insilico Medicine AI Pharma Product

Table 55. Insilico Medicine Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 56. Insilico Medicine Recent Development

Table 57. Exscientia Company Details

Table 58. Exscientia Business Overview

Table 59. Exscientia AI Pharma Product

Table 60. Exscientia Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 61. Exscientia Recent Development

Table 62. BenevolentAI Company Details

Table 63. BenevolentAI Business Overview

Table 64. BenevolentAI AI Pharma Product

Table 65. BenevolentAI Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 66. BenevolentAI Recent Development

Table 67. Atomwise Company Details

Table 68. Atomwise Business Overview

Table 69. Atomwise AI Pharma Product

Table 70. Atomwise Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 71. Atomwise Recent Development

Table 72. Roivant Sciences Company Details

Table 73. Roivant Sciences Business Overview

Table 74. Roivant Sciences AI Pharma Product

Table 75. Roivant Sciences Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 76. Roivant Sciences Recent Development

Table 77. Schrödinger Company Details

Table 78. Schrödinger Business Overview

Table 79. Schrödinger AI Pharma Product

Table 80. Schrödinger Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 81. Schrödinger Recent Development

Table 82. Lantern Pharma Company Details

Table 83. Lantern Pharma Business Overview

Table 84. Lantern Pharma AI Pharma Product

Table 85. Lantern Pharma Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 86. Lantern Pharma Recent Development

Table 87. XtalPi Company Details

Table 88. XtalPi Business Overview

Table 89. XtalPi AI Pharma Product

Table 90. XtalPi Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 91. XtalPi Recent Development

Table 92. Landos Biopharma Company Details

Table 93. Landos Biopharma Business Overview

Table 94. Landos Biopharma AI Pharma Product

Table 95. Landos Biopharma Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 96. Landos Biopharma Recent Development

Table 97. Relay Therapeutics Company Details

Table 98. Relay Therapeutics Business Overview

Table 99. Relay Therapeutics AI Pharma Product

Table 100. Relay Therapeutics Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 101. Relay Therapeutics Recent Development

Table 102. Accutar Biotech Company Details

Table 103. Accutar Biotech Business Overview

Table 104. Accutar Biotech AI Pharma Product

Table 105. Accutar Biotech Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 106. Accutar Biotech Recent Development

Table 107. Deep Genomics Company Details

Table 108. Deep Genomics Business Overview

Table 109. Deep Genomics AI Pharma Product

Table 110. Deep Genomics Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 111. Deep Genomics Recent Development

Table 112. Oncocross Company Details

Table 113. Oncocross Business Overview

Table 114. Oncocross AI Pharma Product

Table 115. Oncocross Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 116. Oncocross Recent Development

Table 117. AI Therapeutics Company Details

Table 118. AI Therapeutics Business Overview

Table 119. AI Therapeutics AI Pharma Product

Table 120. AI Therapeutics Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 121. AI Therapeutics Recent Development

Table 122. BioMap Company Details

Table 123. BioMap Business Overview

Table 124. BioMap AI Pharma Product

Table 125. BioMap Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 126. BioMap Recent Development

Table 127. METiS Pharmaceuticals Company Details

Table 128. METiS Pharmaceuticals Business Overview

Table 129. METiS Pharmaceuticals AI Pharma Product

Table 130. METiS Pharmaceuticals Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 131. METiS Pharmaceuticals Recent Development

Table 132. NeoX Biotech Company Details

Table 133. NeoX Biotech Business Overview

Table 134. NeoX Biotech AI Pharma Product

Table 135. NeoX Biotech Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 136. NeoX Biotech Recent Development

Table 137. StoneWise Company Details

Table 138. StoneWise Business Overview

Table 139. StoneWise AI Pharma Product

Table 140. StoneWise Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 141. StoneWise Recent Development

Table 142. Deep Intelligent Pharma Company Details

Table 143. Deep Intelligent Pharma Business Overview

Table 144. Deep Intelligent Pharma AI Pharma Product

Table 145. Deep Intelligent Pharma Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 146. Deep Intelligent Pharma Recent Development

Table 147. Gigaceuticals Company Details

Table 148. Gigaceuticals Business Overview

Table 149. Gigaceuticals AI Pharma Product

Table 150. Gigaceuticals Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 151. Gigaceuticals Recent Development

Table 152. Chemical.AI Company Details

Table 153. Chemical.AI Business Overview

Table 154. Chemical.AI AI Pharma Product

Table 155. Chemical.AI Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 156. Chemical.AI Recent Development

Table 157. Artivila Company Details

Table 158. Artivila Business Overview

Table 159. Artivila AI Pharma Product

Table 160. Artivila Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 161. Artivila Recent Development

Table 162. Galixir Company Details

Table 163. Galixir Business Overview

Table 164. Galixir AI Pharma Product

Table 165. Galixir Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 166. Galixir Recent Development

Table 167. Xbiome Company Details

Table 168. Xbiome Business Overview

Table 169. Xbiome AI Pharma Product

Table 170. Xbiome Revenue in AI Pharma Business (2020-2025) & (US$ Million)

Table 171. Xbiome Recent Development

Table 172. Research Programs/Design for This Report

Table 173. Key Data Information from Secondary Sources

Table 174. Key Data Information from Primary Sources

Table 175. Authors List of This Report

List of Figures

Figure 1. AI Pharma Picture

Figure 2. Global AI Pharma Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global AI Pharma Market Share by Type: 2024 VS 2031

Figure 4. Self-developed Oipeline Features

Figure 5. Contract Research Organization (CRO) Features

Figure 6. Other Features

Figure 7. Global AI Pharma Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global AI Pharma Market Share by Application: 2024 VS 2031

Figure 9. Preclinical Stage (Optimization of Lead Compounds, etc.) Case Studies

Figure 10. Clinical Trial Phase (Predicting Treatment Outcome, etc.) Case Studies

Figure 11. AI Pharma Report Years Considered

Figure 12. Global AI Pharma Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global AI Pharma Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global AI Pharma Market Share by Region: 2024 VS 2031

Figure 15. Global AI Pharma Market Share by Players in 2024

Figure 16. Global Top AI Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pharma as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by AI Pharma Revenue in 2024

Figure 18. North America AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America AI Pharma Market Share by Country (2020-2031)

Figure 20. United States AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe AI Pharma Market Share by Country (2020-2031)

Figure 24. Germany AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific AI Pharma Market Share by Region (2020-2031)

Figure 32. China AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America AI Pharma Market Share by Country (2020-2031)

Figure 40. Mexico AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa AI Pharma Market Share by Country (2020-2031)

Figure 44. Turkey AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE AI Pharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Recursion Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 48. Insilico Medicine Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 49. Exscientia Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 50. BenevolentAI Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 51. Atomwise Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 52. Roivant Sciences Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 53. Schrödinger Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 54. Lantern Pharma Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 55. XtalPi Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 56. Landos Biopharma Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 57. Relay Therapeutics Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 58. Accutar Biotech Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 59. Deep Genomics Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 60. Oncocross Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 61. AI Therapeutics Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 62. BioMap Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 63. METiS Pharmaceuticals Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 64. NeoX Biotech Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 65. StoneWise Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 66. Deep Intelligent Pharma Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 67. Gigaceuticals Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 68. Chemical.AI Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 69. Artivila Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 70. Galixir Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 71. Xbiome Revenue Growth Rate in AI Pharma Business (2020-2025)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

AI Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artificial Intelligence AI in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artificial Intelligence Drug Development Market Research Report 2024

Artificial Intelligence For Drug Development and Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Image assisted Diagnosis Software Market Research Report 2025

Global Artificial Intelligence In Diagnostic Market Research Report 2024

AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artificial Intelligence AI in Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024

Artificial Intelligence in IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Imaging and Diagnostics System Market Research Report 2025

Global AI Imaging and Diagnostics Software Market Research Report 2025

AI for Early Cancer Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI enabled Diagnostic Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medicine Compounding Robot Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Treatment Planning Software Market Research Report 2025

Global Medicines for Alzheimer Disease Treatment Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions